CSIMarket


Soligenix inc   (SNGX)
Other Ticker:  
 


 

Soligenix inc

SNGX's Financial Statements and Analysis



Soligenix inc narrowed forth quarter of 2023 net loss per share of $-0.17 compare to net loss per share of $-4.14 recorded in the same quarter a year ago a decrease compare to $-0.16 realized in previous quarter.


forth quarter of 2023
Earnings Per Share Revenues
$ -0.17 $  0 Mill
$+3.97     $+1,773M    



Soligenix Inc 's Revenue rose by -100.01 % in forth quarter of 2023 (Dec 31 2023) year on year, to $0 million and advanced by 87.68 % sequentially.


Soligenix Inc is Expected to report next financial results on March 30, 2024.

More on SNGX's Income Statement



Soligenix Inc 's in theforth quarter of 2023 recorded net loss of $-1.820 million, an improvement compare to net loss of $-11.901 million in IV. Quarter a year ago.

Sequentially net loss advanced

More on SNGX's Growth

Soligenix Inc Inventories
In Dec 31 2023 company's net cash and cash equivalents decreased by $-2 million


Soligenix inc does not pay out common stock dividend.

In trailing twelve-month period Soligenix inc payed $ -1.19 cash per share, on a free-cash flow basis .

Book value fell by -14.41 % sequentially to $0.35 per share, -6.14% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.35 per share from $ 0.41.

Company repurchased 3.13 million shares or 30.19 % in Dec 31 2023.


More on SNGX's Dividends

 Market Capitalization (Millions) 4
 Shares Outstanding (Millions) 7
 Total Debt (Millions $) 3
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Soligenix inc does not pay out common stock dividend.

In trailing twelve-month period Soligenix inc had negative $ -1.19 cash flow per share, on a free-cash flow basis .

Book value fell by -14.41 % sequentially to $0.35 per share, -6.14% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.35 per share from $ 0.41.

Company repurchased 3.13 million shares or 30.19 % in Dec 31 2023.


More on SNGX's Balance Sheets

 Market Capitalization (Millions) 4
 Shares Outstanding (Millions) 7
 Total Debt (Millions $) 3
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Soligenix inc Earnings

Soligenix Inc Narrows Fourth Quarter Shortfall 2.

As a financial journalist for the , I have been closely following the recent financial results of Major Pharmaceutical Preparations company, Soligenix Inc. The company's performance in the October to December 31, 2023 period has shown some improvement compared to the previous year.
In the fourth quarter of 2023, Soligenix Inc reported a net shortfall of $-1.820 million, a significant improvement from the $-11.901 million deficit in the same quarter a year ago. The company also managed to reduce its shortfall per share to $-0.17 from $-4.14 in the previous year, indicating progress in their financial performance.
Despite the positive changes, Soligenix Inc's revenue deteriorated by -11.55% from $0.95...

Soligenix Inc Reports Disappointing Financial Results: Deficit Doubles in Most Recent Fiscal Period

Over the past week, Soligenix Inc stock has experienced a slight drop of -0.2%. This decline ...

Soligenix Inc witnesses an impressive revenue surge in Q1 2023, showcasing robust growth

Soligenix Inc is a healthcare company that has recently released its fiscal period financial results. These results show that the company experienced a significant increase in diminishing returns, with a per share value of -$0.36, compared to -$0.06 in the previous year. However, the company's EPS improved from -$4.14 per share in the preceding reporting season.
One positive aspect of Soligenix Inc's financial performance is the strong growth in revenue, which rose by 74.248% to $0.26 million from $0.15 million in the same reporting season a year prior. Additionally, the company's revenue turned positive from -$1,772.95 million sequentially. Despite these improvements, Soligenix Inc realized a net shortf...


Date modified: 2024-03-18T20:26:16+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com